China ’ s large number of pharmaceutical companies lack core technology and intellectual property rights , more than 97%of the chemicals are generic with serious convergence , leading to a repeated low-level vicious cycle .Standardize drug safety informat ......
——《Healthy China 2020:strategic research report》
书名:《Healthy China 2020:strategic research report》
栏目:Healthy China 2020:strategic research report > Segment reports > Drug Policy Research1 > aPPendIx: suMMary of focus grouP research rePort
作者:陈竺
参编:DaiTao,HuShanlian,ChenXianyi,ChenYingyao,LiXiang
页码:174-175
版本:1
出版社:人民卫生出版社
出版时间:2013-08-01